Kerstin Buck

474 total citations
14 papers, 374 citations indexed

About

Kerstin Buck is a scholar working on Neurology, Cellular and Molecular Neuroscience and Cognitive Neuroscience. According to data from OpenAlex, Kerstin Buck has authored 14 papers receiving a total of 374 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Neurology, 12 papers in Cellular and Molecular Neuroscience and 2 papers in Cognitive Neuroscience. Recurrent topics in Kerstin Buck's work include Parkinson's Disease Mechanisms and Treatments (12 papers), Neurological disorders and treatments (10 papers) and Neuroscience and Neuropharmacology Research (5 papers). Kerstin Buck is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (12 papers), Neurological disorders and treatments (10 papers) and Neuroscience and Neuropharmacology Research (5 papers). Kerstin Buck collaborates with scholars based in Germany, Sweden and United States. Kerstin Buck's co-authors include Boris Ferger, Deniz Kirik, Ayşe Ulusoy, Tomas Björklund, Natalie Landeck, Anthony P. Nicholas, Nour K. Majbour, Erich Buerger, Eliza Koroś and Omar M. A. El‐Agnaf and has published in prestigious journals such as Neuroscience, Journal of Neurochemistry and European Journal of Neuroscience.

In The Last Decade

Kerstin Buck

14 papers receiving 369 citations

Peers

Kerstin Buck
Sandra L. Castro United States
U Mach Germany
Megan J. Dowie New Zealand
April Dukes United States
Liang Tan Singapore
Kerstin Buck
Citations per year, relative to Kerstin Buck Kerstin Buck (= 1×) peers Dominique Bédard

Countries citing papers authored by Kerstin Buck

Since Specialization
Citations

This map shows the geographic impact of Kerstin Buck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kerstin Buck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kerstin Buck more than expected).

Fields of papers citing papers by Kerstin Buck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kerstin Buck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kerstin Buck. The network helps show where Kerstin Buck may publish in the future.

Co-authorship network of co-authors of Kerstin Buck

This figure shows the co-authorship network connecting the top 25 collaborators of Kerstin Buck. A scholar is included among the top collaborators of Kerstin Buck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kerstin Buck. Kerstin Buck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Landeck, Natalie, Katherine E. Strathearn, Daniel Ysselstein, et al.. (2020). Two C-terminal sequence variations determine differential neurotoxicity between human and mouse α-synuclein. Molecular Neurodegeneration. 15(1). 49–49. 12 indexed citations
2.
Landeck, Natalie, Sarah Sonnay, Kerstin Buck, et al.. (2016). Assessment of brain metabolite correlates of adeno‐associated virus‐mediated over‐expression of human alpha‐synuclein in cortical neurons by in vivo1H‐MR spectroscopy at 9.4 T. Journal of Neurochemistry. 137(5). 806–819. 4 indexed citations
3.
Landeck, Natalie, Kerstin Buck, & Deniz Kirik. (2016). Toxic effects of human and rodent variants of alpha‐synuclein in vivo. European Journal of Neuroscience. 45(4). 536–547. 21 indexed citations
4.
Buck, Kerstin, Natalie Landeck, Ayşe Ulusoy, et al.. (2015). Ser129 phosphorylation of endogenous α-synuclein induced by overexpression of polo-like kinases 2 and 3 in nigral dopamine neurons is not detrimental to their survival and function. Neurobiology of Disease. 78. 100–114. 20 indexed citations
5.
Ulusoy, Ayşe, Tomas Björklund, Kerstin Buck, & Deniz Kirik. (2012). Dysregulated dopamine storage increases the vulnerability to α-synuclein in nigral neurons. Neurobiology of Disease. 47(3). 367–377. 48 indexed citations
7.
Buck, Kerstin & Boris Ferger. (2010). l-DOPA-induced dyskinesia in Parkinson's disease: a drug discovery perspective. Drug Discovery Today. 15(19-20). 867–875. 29 indexed citations
10.
Buck, Kerstin, et al.. (2009). Rapid analysis of GABA and glutamate in microdialysis samples using high performance liquid chromatography and tandem mass spectrometry. Journal of Neuroscience Methods. 182(1). 78–84. 78 indexed citations
11.
Buck, Kerstin & Boris Ferger. (2009). The selective α1adrenoceptor antagonist HEAT reduces L‐DOPA‐induced dyskinesia in a rat model of Parkinson's disease. Synapse. 64(2). 117–126. 23 indexed citations
13.
Nicholas, Anthony P., Kerstin Buck, & Boris Ferger. (2008). Effects of levodopa on striatal monoamines in mice with levodopa-induced hyperactivity. Neuroscience Letters. 443(3). 204–208. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026